BioCryst Pharmaceuticals | BCRX - PE Price to Earnings


BioCryst Pharmaceuticals reported 6.06 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
BioCryst Pharmaceuticals 6.06 1.07K Dec/2025
Chugai Pharma 31.26 5.24 Dec/2025
Daiichi Sankyo 20.73 1.74 Dec/2025
Gilead Sciences 15.63 0.08 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
Glaxosmithkline 11.66 0.28 Dec/2025
Incyte 14.84 2.79 Dec/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Neurocrine Biosciences 835.47 802.2 Dec/2025
Novavax 2.01 1.07 Dec/2025
PTC Therapeutics 9.98 3.25 Dec/2025
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Sarepta Therapeutics 27.27 0 Sep/2025
Vertex Pharmaceuticals 26.15 2.22 Dec/2025